FDA Adverse Event Other Summary report: N

INVISALIGN SYSTEM

MDR report key: 2474254 · Received February 28, 2012

Report

Report Number
2953749-2012-00050
Event Type
Other
Date Received
February 28, 2012
Date of Event
February 16, 2012
Report Date
February 16, 2012
Manufacturer
ALIGN TECHNOLOGY INC
Product Code
NXC
PMA / PMN Number
K081960
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE ALIGNERS ARE NOT BEING EVALUATED (METHOD) AS THE PRODUCT PERFORMED IN ACCORDANCE TO SPECS (RESULTS, CONCLUSION) AND THE DEVICE WAS USED IN ACCORDANCE WITH LABELED INDICATIONS (RESULTS). THIS EVENT IS BEING FILED AS AN MDR, BECAUSE THE PT INDICATED VISITING THE ER AND THE ER DOCTORS FELT THE PT WAS SUFFERING FROM A TYPE OF ANAPHYLACTIC REACTION. NO ADD'L REPORTS WERE PROVIDED. NO EVIDENCE HAS BEEN PROVIDED THAT SUPPORTS OR OPPOSES, THE FACT THAT THE INVISALIGN PRODUCT CAUSED OR CONTRIBUTED TO THE PT SYMPTOMS. BASED ON THE ER DOCTOR'S OPINION OF THE POTENTIAL ANAPHYLACTIC EPISODE, AND SINCE INVISALIGN PRODUCT WAS BEING USED AT THE TIME OF THE REPORTED SYMPTOMS, A MDR IS BEING FILED.

Description of Event or Problem · 1

THE TREATMENT STARTED ON (B)(6) 2012. THE PT REPORTED THE SYMPTOMS OF SWOLLEN HANDS, FEET, TONGUE AND LIPS, HIVES ON THE PT'S FACE THAT PROGRESSIVELY EXTENDED TO THE WHOLE BODY, AND BREATHING DIFFICULTIES. THE PT INDICATED VISITING THE ER (ER) ON (B)(6) 2012. THE ER DOCTORS FELT THAT THE PT WAS SUFFERING FROM A TYPE OF ANAPHYLACTIC REACTION, BUT NO ADD'L REPORTS WERE PROVIDED. THE PT DISCONTINUED THE TREATMENT ON (B)(6) 2012. THIS EVENT IS CONSIDERED TO BE POTENTIALLY SERIOUS IN NATURE OR LIFE-THREATENING TO THE PT DUE TO POSSIBILITY OF THIS EVENT BEING AN ANAPHYLACTIC EPISODE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INVISALIGN SYSTEM SEQUENTIAL ALIGNERS - ORTHODONTIC DEVICE NXC ALIGN TECHNOLOGY INC INVISALIGN FULL 4213941

Patients

Seq Age Sex Outcome Treatment
1 22 YR Other